Compared with the positive control and screening results, it was found that HLJD anti-inflammatory components could act on two key inflammatory proteins, COX-2 and 5-LOX, of which 19 HLJD components had anti-inflammatory effects and were effective against cerebral ischemia. The gene discussed is PROS1; the disease is brain ischemia.